![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
NeuroVive Pharmaceutical AB announced that the US Food and Drug Administration, FDA, has approved NeuroVive’s IND (Investigational New Drug) application, enabling clinical studies in the US with the
Novartis phase III EXPAND study shows treatment with Mayzent has clinically meaningful positive impact on CPS in patients with SPMS
Novartis announced a new analysis of the phase III EXPAND study, demonstrating that treatment with Mayzent (siponimod) had a clinically meaningful positive impact on cognitive processing speed (CPS) in patients with...
Bristol-Myers’ Opdivo fails late-stage brain cancer trial
Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in patients with an aggressive form of tumor that affects the brain or the spine.
Groen licht voor drie middelen
De Committee for Medicinal Products for Human Use (CHMP) heeft een positief advies gegeven over nieuwe handelsvergunningen voor drie geneesmiddelen. Het oncolyticum lorlatinib (Lorviqua) ontving een voorwaardelijke...
AZ ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia
AstraZeneca has unveiled new Phase 3 data on the efficacy of its Bruton tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) in the treatment of previously-treated patients with chronic lymphocytic leukaemia (CLL)...
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary endpoints in a randomised, double blind, clinical study of patients with Tuberous Sclerosis Complex...
Eli Lilly’s Emgality shows positive Phase 3 results in treatment of migraine
Eli Lilly has announced positive results from the Phase 3 EVOLVE-1 and EVOLVE-2 trials looking into Emgality (galcanezumab-gnlm) for the treatment of episodic migraine. The drug was found to reduce the number of...
Geneesmiddelentekorten in Nederland lopen steeds verder op
“Sorry, dit geneesmiddel is niet meer leverbaar.” Het komt steeds vaker voor dat wij als apothekers nee moeten verkopen aan onze klanten en patiënten. Rond deze tijd vorig jaar meldde de NOS een ‘explosieve groei van...
Pfizer receives US FDA approval for Vyndaqel & Vyndamax to treat patients with transthyretin amyloid cardiomyopathy
Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved both Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for the treatment of the cardiomyopathy of wild─type or hereditary
Pfizer scores conditional European approval in ALK-positive lung cancer with Lorviqua
Pfizer’s Lorviqua (lorlatinib), or Lorbrena as it is known in the US, Canada and Japan, has just been awarded conditional marketing approval from the European Commission (EC) for the treatment of anaplastic lymphoma...
The significance of artificial intelligence in drug delivery system design
Over the last decade, increasing interest has been attracted towards the application of artificial intelligence (AI) technology for analyzing and interpreting the biological or genetic information, accelerated drug...
EU nod for BioMarin’s second PKU therapy Palynziq
BioMarin has gained European Union approval for Palynziq (pegvaliase injection) for the rare metabolic condition phenylketonuria (PKU). The EU decision comes a year after the FDA approval of the treatment, which is...
Aptamer Therapeutics collaborates with Cancer Research UK for drug development program
Following the successful awarding of a CRUK Biotherapeutic Drug Discovery Project Award, Aptamer Therapeutics Limited, part of Aptamer Group, is pleased to announce a new collaboration with Dan Wiseman and the Oglesby...
GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol: FF/UMEC/VI) in the treatment of uncontrolled...
Wat communicatie en marketing verbindt
Marketing- en communicatieafdelingen hoeven niet te integreren, maar moeten wel meer naar elkaar kijken, stelt Betteke van Ruler.
Professional Talk: “Ik wil de complexe marketingwereld simpel maken”
Ment Kuiper heeft ruim 20 jaar ervaring in het marketingvak. Hij is programma- en innovatiemanager bij SCHAAL+ en eind vorig jaar bracht hij zijn eerste boek ‘Marketingplan op 1 A4’ uit. Hij vindt dat marketeers beter...
Groei gebruik van Virtual Reality (VR) in de gezondsheidszorg
Het gebruik van Virtual Reality (VR) in de gezondsheidszorg groeit in een rap tempo. Dat is een van de conclusies uit het VR Health Event tijdens de Dutch Technology Week in Eindhoven, waarbij vooral is gekeken naar...
Groen licht voor volanesorsen
De Committee for Medicinal Products for Human Use (CHMP) heeft een positief advies gegeven over een voorwaardelijke handelsvergunning voor volanesorsen (Waylivra). Het is het eerste geneesmiddel voor de behandeling van...
